First Tracks Biotherapeutics When-Issued

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch TRAXV and buy or sell other stocks, ETFs, and their options commission-free!

About TRAXV

First Tracks Biotherapeutics, Inc. engages in the research and development of immunology therapeutics for autoimmune and inflammatory diseases. It focuses on clinical-stage programs for rosnilimab, ANB033 and ANB101. 

CEO
Daniel R. Faga
CEODaniel R. Faga
Employees
—
Employees—
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
Founded
Employees
—
Employees—

TRAXV Key Statistics

Market cap
—
Market cap—
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
3.15K
Average volume3.15K
High today
$24.50
High today$24.50
Low today
$21.40
Low today$21.40
Open price
$22.00
Open price$22.00
Volume
13.67K
Volume13.67K
52 Week high
$25.00
52 Week high$25.00
52 Week low
$19.00
52 Week low$19.00

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.